Skip main navigation

Cookies Notification

We use cookies on this site to enhance your user experience. By continuing to browse the site, you consent to the use of our cookies. Learn More
×

System Upgrade on Tue, May 28th, 2024 at 2am (EDT)

Existing users will be able to log into the site and access content. However, E-commerce and registration of new users may not be available for up to 12 hours.
For online purchase, please visit us again. Contact us at customercare@wspc.com for any enquiries.

SEARCH GUIDE  Download Search Tip PDF File

  • articleNo Access

    BIOBOARD

      AUSTRALIA – Well-known antibiotic amoxycillin found to be ineffective cough treatment.

      AUSTRALIA – Bring the noise: has technology made us scared of silence?

      INDIA – Biocon receives marketing authorization for novel biologic itolizumab for psoriasis.

      ISRAEL – Aspireo reports Somatoprim Phase Ib interim data.

      JAPAN – Daiichi Sankyo and Amplimmune announce strategic alliance to develop AMP-110 therapy for autoimmune disease.

      JAPAN – Eisai signs agreement with Epizyme and Roche Molecular Systems to develop companion diagnostic.

      THE PHILIPPINES – Asia-Pacific Analysis: The growth of stem-cell therapy.

      THE PHILIPPINES – Is the world ready for scientific diplomacy?

      UNITED KINGDOM – ARIAD and the U.K. National Cancer Research Institute to collaborate on SPIRIT 3 clinical study.

      UNITED KINGDOM – Vision research collaboration on novel treatment for wet age-related macular degeneration.

      UNITED STATES – Reducing medical mistakes: Two recently published studies support the use of DNA testing on biopsy samples to prevent misdiagnoses.

      UNITED STATES – CoDa Therapeutics reports positive results from Phase IIb Study of NEXAGON® in chronic venous leg ulcers.

      UNITED STATES – Inovio Pharmaceuticals to initiate clinical trial for its hepatitis C therapeutic vaccine later this year.

      UNITED STATES – Jolt to brain eases pain without drugs.

      UNITED STATES – Can a new vaccine prevent colon cancer?

      UNITED STATES – Immunovaccine's DPX-Survivac produces sustained, dose related immune responses in Phase I ovarian cancer study.

    • chapterNo Access

      COMMUNICATION, SILENCE AND MISCOMMUNICATION

      The classical theories about communication have different views on the relevance of the requirement of the intentionality of the communicative agent. The composition of these views seems to be problematic since it leads to incompatible outcomes when we try to classify communicative behaviors. Some approaches, in order to build a synthesis, shift on the addressee the task of detecting the intentionality and thus cannot account for a number of interesting communicative phenomena. The systemic perspective instead, through the circularity of the inferences on system elements and the sharing of the attributes and the overall communicative characteristics of the system, defines, specifies and more generalizes the concept of communication, enabling to better single out the variety of phenomena connected to it and to catch the emergence of their communicative value.